TickerFactsScreenerDevelopers

DiaMedica Therapeutics Inc. (DMAC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$3.90M2018: -$5.70M2019: -$9.10M2020: -$9.19M2021: -$12.25M2022: -$11.51M2023: -$18.73M2024: -$22.08M2025: -$29.06M-$29.06M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$29.06M-31.6%
2024-$22.08M-17.9%
2023-$18.73M-62.7%
2022-$11.51M+6.0%
2021-$12.25M-33.4%
2020-$9.19M-0.9%
2019-$9.10M-59.8%
2018-$5.70M-46.1%
2017-$3.90M—